FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

46558003: Imipenem (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
77597011 Imipenem en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
77598018 Imipemide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
77600012 N-formimidoythienamycin en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
77601011 N-F-thienamycin en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
783920010 Imipenem (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2699001000005113 Imipenem da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Imipenem Is a beta-lactam-antibiotikum false Inferred relationship Some
Imipenem Is a Baktericid false Inferred relationship Some
Imipenem Is a Carbapenem (substance) true Inferred relationship Some
Imipenem This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some
Imipenem Is a Substance with beta-lactam structure and antibacterial mechanism of action (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Imipenem with cilastin sodium Is a False Imipenem Inferred relationship Some
Imipenem and cilastatin measurement Has measured component False Imipenem Inferred relationship Some
Imipenem measurement Has measured component False Imipenem Inferred relationship Some
Imipenem and cilastatin measurement Component True Imipenem Inferred relationship Some 1
Imipenem measurement Component True Imipenem Inferred relationship Some 1
Product containing cilastatin and imipenem (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Imipenem Inferred relationship Some 1
imipenem 500 mg + cilastatin 500 mg pulver til infusionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Imipenem Inferred relationship Some
imipenem 500 mg + cilastatin 500 mg pulver til injektionsvæske, suspension, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Imipenem Inferred relationship Some
Imipenem 500mg/cilastatin 500mg powder for infusion solution transfer vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Imipenem Inferred relationship Some
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Imipenem Inferred relationship Some
imipenem 750 mg + cilastatin 750 mg pulver til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Imipenem Inferred relationship Some
Product containing imipenem (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Imipenem Inferred relationship Some 1
Allergy to imipenem Causative agent False Imipenem Inferred relationship Some
Allergy to imipenem Causative agent True Imipenem Inferred relationship Some 1
Cilastatin- and imipenem-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Imipenem Inferred relationship Some 1
Imipenem monohydrate (substance) Is a False Imipenem Inferred relationship Some
imipenem 500 mg + cilastatin 500 mg pulver til injektionsvæske, suspension, hætteglas This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Imipenem Inferred relationship Some 2
Imipenem monohydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Imipenem Inferred relationship Some
Cilastatin and imipenem only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Imipenem Inferred relationship Some 1
Imipenem only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Imipenem Inferred relationship Some 1
Product containing only cilastatin and imipenem in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Imipenem Inferred relationship Some 1
Imipenem anhydrous (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Imipenem Inferred relationship Some
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Imipenem Inferred relationship Some 1
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Imipenem Inferred relationship Some 1
Product containing cilastatin and imipenem and relebactam (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Imipenem Inferred relationship Some 1
Product containing only cilastatin and imipenem and relebactam (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Imipenem Inferred relationship Some 1
Product containing cilastatin and imipenem and relebactam in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Imipenem Inferred relationship Some 1
Cilastatin and imipenem and relebactam only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Imipenem Inferred relationship Some 1
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release suspension for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Imipenem Inferred relationship Some 1
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release suspension for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Imipenem Inferred relationship Some 1
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Imipenem Inferred relationship Some 1
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Imipenem Inferred relationship Some 1
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Imipenem Inferred relationship Some 1
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Imipenem Inferred relationship Some 1
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg powder for solution for infusion and/or injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Imipenem Inferred relationship Some 1
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg powder for solution for infusion and/or injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Imipenem Inferred relationship Some 1

This concept is not in any reference sets

Back to Start